← Every applicant
Kindos FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DALBAVANCIN HYDROCHLORIDENew drugNov 26, 2025POWDER, INTRAVENOUS |
| HYDRALAZINE HYDROCHLORIDENew drugJun 2, 2025INJECTABLE, INJECTION |
| FLUOROURACILNew drugFeb 6, 2025INJECTABLE, INJECTION |
| DOXYCYCLINE HYCLATENew drugOct 28, 2024INJECTABLE, INJECTION |
| FLUOROURACILNew drugSep 24, 2024INJECTABLE, INJECTION |
| ROPIVACAINE HYDROCHLORIDENew drugJul 30, 2024SOLUTION, INJECTION |